
Canadian telecommunications giant Rogers announced on Monday it would send out consent solicitations to extend the terms of bonds worth a collective $7.05 billion USD and $3 billion CAD that it issued to finance its proposed $26 billion CAD acquisition of Shaw.
The Toronto-based telecom giant currently has until the end of the year to close the Shaw deal. If it fails to do so, Rogers will have to repay its lenders 101 cents on the dollar. Rogers wants to extend that deadline to December 31, 2023, as the Shaw acquisition continues to hang in the balance.
Rogers is a wireless phone operator with presence across Canada, also offering additional services (Cable, Internet) in the provinces of Ontario, New Brunswick, and Newfoundland and Labrador. Shaw is a major cable provider in Western Canada and also owns Canada’s fourth largest mobile provider, Freedom Mobile.
Canada’s parliament has held hearings on the merger, where analysts and academics have objected to the likely elimination of Freedom Mobile as a fourth competitor in the mobile phone sector, helping keep competition down. Rogers also offered several compromises and ‘sweeteners’ to regulators, hoping to secure authorization for the deal, including a commitment to spend $2.5 billion on 5G build-out in Western Canada and $1 billion to connect remote rural and native communities.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas